Stifel Nicolaus Reaffirms Their Hold Rating on Bruker (BRKR)
Stifel Nicolaus analyst Daniel Arias maintained a Hold rating on Bruker (BRKR – Research Report) today and set a price target of $57.00. The ...
Le Lézard2d
Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to the ...